A 60 year old female presented with breast carcinoma and she was prescribed herceptin (trastuzumab). Which of the following statement regarding this drug is TRUE?
Correct Answer: It is a monoclonal antibody produced by injecting her-2 antigen
Description: Trastuzumab (HERCEPTIN) is a humanized monoclonal antibody that binds to the external domain of HER2/neu (ErbB2). Trastuzumab was the first monoclonal antibody to be approved for the treatment of a solid tumor. Thiy percent of breast cancers overexpress this receptor due to gene amplification on chromosome 17. Also Know: Trastuzumab exes its antitumor effects through several putative mechanisms of action: inhibition of homo- or heterodimerization of receptor, thereby preventing receptor kinase activation and downstream signaling; initiation of Fc-receptor-mediated antibody-dependent cellular cytotoxicity; and blockade of the angiogenic effects of HER2 signaling. Ref: Chabner B.A., Barnes J., Neal J., Olson E., Mujagic H., Sequist L., Wilson W., Longo D.L., Mitsiades C., Richardson P. (2011). Chapter 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In L.L. Brunton, B.A. Chabner, B.C. Knollmann (Eds), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now